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ABSTRACT
Considerable effort has been directed towards studying
the structure and function of oligonucleotides and
several approaches rely on the attachment of reporter
groups to oligonucleotides. We report here the
introduction of 3′- and 5′-terminal phosphorothioates
into heptameric oligonucleotides and their post-
synthetic modification with several reporter groups.
The synthesis of terminal phosphorothioates is based
on the coupling of a ribonucleoside phosphoramidite
at the first or last nucleotide, respectively, which, after
sulphurization, is removed by sequential oxidation of
the vicinal hydroxyl groups and then β-elimination.
Product formation is of the order of 95%. The ratio of
phosphorothioate- versus phosphate-terminated
oligodeoxynucleotides as analysed by electrophoresis
on a Hg2+ gel is in general 85/15. Examples for the
reactivity of the terminal phosphorothioates for
conjugation with cholesterol, bimane and for sulphydryl
exchange are described.
INTRODUCTION
The conjugation of reporter groups or groups promoting cellular
uptake are useful in a number of applications (1–3). The
attachment of such groups onto oligonucleotides can be achieved
either by their incorporation during chemical synthesis (4) or by
post-synthetic modifications (5,6). In the latter case it is desirable
to have an oligonucleotide with amino or sulphydryl linkers
which often are commercially available as phosphoramidites and
can be incorporated during oligonucleotide synthesis (7–14) or
oxidative phosphoramidation with substituted amines (15).
Alternatively, reactive sulphydryls in the form of terminal
phosphorothioates can be introduced. These have been introduced
by chemical 5′-phosphorylation with different phosphoramidites
and subsequent sulphurization (16–19) or by enzymatic transfer
with ATPγS and T4 polynucleotide kinase (20,21). We found it
desirable to develop an alternative method to introduce terminal
phosphorothioates for further derivatization. We describe here
such a method consisting of the introduction of a terminal
ribonucleoside phosphorothioate which upon oxidation of the
vicinal hydroxyl groups and subsequent β-elimination generates
the desired phosphorothioate, either on the 5′- or the 3′-terminus of
the oligonucleotide. The reactivity of the terminal phosphorothioates
is demonstrated by coupling of cholesterol, bromobimane and
dithiodipyridine derivatives to these oligonucleotides.
RESULTS AND DISCUSSION
The use of oligonucleotides often requires functionalization at the
termini for the attachment of fluorescent probes like bromobimane
(8,10,13) or hydrophobic groups like cholesterol
(7,9,11,12,14,15). The application of reactive sulphydryl groups
in the form of terminal phosphorothioates have proven suitable
for this purpose as outlined in the Introduction. Often the
incorporation of terminal phosphorothioates into oligonucleotides
results in poor yields or during the chemical synthesis in side
products (22). As an alternative, the possibility of introducing the
phosphorothioate group initially as an internucleotidic linkage by
standard methods and then conversion into a phosphorothioate
monoester by removal of the terminal nucleoside was explored.
The introduction of terminal phosphates into oligonucleotides
by protection with a ribnucleoside and its subsequent removal by
oxidation and β-elimination was first described for a trinucleotide
(23). The application of this procedure to the preparation of
phosphorothioates such as ATPγS and ADPβS has been described,
illustrating that oxidation conditions can be found where the
phosphorothioate is stable (24).
Here an adaptation of these procedures is described to
synthesise terminal phosphorothioate-containing oligonucleotides.
For the synthesis of a 3′-terminal phosphorothioate-containing
oligodeoxynucleotide, the synthesis is started with a uridine
attached to CPG and sulphurization of the internucleotidic bond
after the first coupling. Subsequent NaIO4 oxidation cleaves the
vicinal hydroxyl group to a dialdehyde which is subjected to a
β-elimination reaction to generate the terminal phosphorothioate. An
example for this sequence of reactions is given in Figure 1 for the
synthesis of oligodeoxynucleotide C. An analogous sequence of
reactions is applied for the introduction of a 5′-terminal phosphoro-
thioate as outlined for the synthesis of oligodeoxynucleotide F in
Figure 2.
The same reaction sequence for the introduction of a phosphoro-
thioate at the 3′-end of oligoribonucleotides did not yield the
expected product. Although the mechanism for the interfering
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Figure 1. Synthesis of oligodeoxynucleotide 5′-phosphorothioate C.
reaction has not been elucidated, it is conceivable that the sulphur
of the phosphorothioate adds to the β-elimination product,
resulting in an oligonucleotide terminating with a 3′-phosphoro-
thioate-S-ester (Fig. 3, III). This is analogous to the addition of
thiophosphoric acid to acrylonitrile (25). Compound III would be
subject to a phosphoryl transfer by nucleophilic attack of the 2′-OH
group resulting in a terminal nucleoside 2′,3′-cyclic phosphate
(Fig. 3, IV and V). There is precedence for the cyclisation reaction
as it has been shown that nucleoside 3′-phosphorothioate-S-esters
readily lead to nucleoside 2′,3′-cyclic phosphates as the S-esters are
excellent leaving groups (23).
To prevent this undesired reaction in the synthesis of oligoribo-
nucleotide 3′-phosphorothioate, a deoxynucleoside phospho-
ramidite was coupled to the penultimate position of the oligoribo-
nucleotide as shown for the synthesis of I (Fig. 4). Thus the
oligoribonucleotide has a deoxynucleotide at the 3′-terminal
position which is generally not expected to interfere with
application of such an oligonucleotide.
These reaction sequences proceed with good yields. The
compounds give the calculated values in mass spectrometry and
the 31P NMR spectra show the expected distribution between
phosphate and phosphorothioate signals (Fig. 5 gives an
example). The ratio of phosphorothioate- and phosphate-terminated
oligonucleotides was quantified by gel electrophoresis on a Hg2+
gel after 32P-labelling (20). In this analysis the phosphorothioate-
terminated oligonucleotides, in contrast to the phosphate-terminated
ones, do not migrate in the gel because of their interaction with
the Hg2+. This separation allows for easy quantification. The ratio
of phosphorothioate versus phosphate for the oligonucleotides
prepared here was in general 85/15. The small content of
phosphate presumably derives from some loss of sulphur during
the oxidation step. The reactivity of an internucleotidic phosphoro-
thioate group towards NaIO4 oxidation under the conditions
employed here was investigated with Tp(S)T. Judging by HPLC
analysis ∼15% reaction to TpT was observed. Thus, if the
introduction of a terminal phosphorothioate group is carried out with
an oligonucleotide containing phosphorothioate internucleotidic
linkages a small loss of sulphur will have to be expected.
Figure 2. Synthesis of oligodeoxynucleotide 3′-phosphorothioate F.
The terminal phosphorothioates are phosphorothioate monoesters
and as such react readily with thiophilic moieties (8,10,13,
18,21,26–29). This was confirmed for the compounds prepared
by the oxidation–β-elimination procedure by derivatization of
oligodeoxynucleotide C with bromobimane, dithiodipyridine,
α-bromoacetamide 3-cholestesterol and 2-(5′-nitropyridyl)-
3-cholesterol disulphide to compounds J–M which were also
characterised by mass spectrometry (Fig. 6).
The phosphorothioate internucleotidic linkage of an oligo-
nucleotide can be alkylated at elevated temperature over several
hours with thiophiles similar to those employed here (30). It was
therefore of interest to compare the reactivity between a
phosphorothioate diester and a monoester such as a terminal
phosphorothioate described here. This was done by reacting
Tp(S)T with bromobimane as an example as this is the most
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Figure 3. Cleavage of an internucleotidic phosphorothioate in an oligoribo-
nucleotide.
reactive compound described for reaction with oligonucleotides
containing one internucleotidic phosphorothioate. Interestingly,
the terminal phosphorothioate of F reacted only marginally faster
than that of Tp(S)T. Thus, caution has to be exercised when reacting
terminal phosphorothioates of oligonucleotides which additionally
also contain a phosphorothioate internucleotidic linkage.
The high yields of this synthetic method for the introduction of
terminal phosphorothioates at either the 3′- or the 5′-end of an
oligonucleotide establishes an attractive alternative to the use of
linkers or enzymatic phosphorothioation.
MATERIALS AND METHODS
General
Synthesis of oligonucleotides was carried out by the phospho-
ramidite method on an Applied Biosystems DNA Synthesizer 380 B
on a 1 µmol scale with nucleoside phosphoramidites from
PerSeptive (Hamburg, Germany). 2′,3′-Diacetyluridine-5′-O-
(2-cyanoethoxydiisopropylamino)phosphoramidite was either
prepared by standard procedures (31) or obtained commercially
from ChemGenes (Waltham, MA). Bromobimane was purchased
from Sigma (Deisenhofen, Germany), dithiodipyridine from
Fluka (Neu-Ulm, Germany), 1,8-bis-(dimethylamino)naphthalene,
bromoacetyl bromide, bis-(5-nitro-2-pyridyl)disulphide and thio-
cholesterol from Aldrich (Steinheim, Germany) and SiO2
(particle size 0.063–0.200 mm) from Merck (Darmstadt, Germany).
All reactions of the phosphorothioate oligonucleotides were
conducted in an argon atmosphere.
Figure 4. Synthesis of the oligoribonucleotide 3′-phosphorothioate I.
1H and 13C NMR were recorded in CDCl3 on a Bruker AM
360L spectrometer at 360.13 and 90.55 MHz, respectively.
Chemical shifts are reported in p.p.m., relative to tetramethylsilane
at δ 0.0 p.p.m. 31P NMR spectra were recorded at 145.79 MHz.
Chemical shifts are reported in p.p.m., relative to 80% phosphoric
acid as external standard at δ 0.0 p.p.m.
Oligonucleotides were characterised by MALDI-TOF mass
detection on a PerSeptive Biosystems Voyager-DE Biospectrometry
Workstation with 3-hydroxypicolinic acid in ammonium citrate
as matrix.
HPLC analysis was carried out on a Waters Associates System
with Model 6000A pumps, a Module 680 Automated System
Controller, a Model 730 Data Module and a Model 481 LC
Spectrophotometer. Reverse phase HPLC was performed on
Hypersil ODS 5 µm columns (MZ Analysetechnik, Mainz,
Germany) with a stepwise gradient of 0–16% acetonitrile in 50 mM
triethyl ammonium acetate (pH 7.0) for 15 min, followed by an
increase of acetonitrile from 16 to 70% from 15 to 20 min and
keeping this buffer for up to 30 min for analytical runs. The same
gradient was used for preparative runs but with 100 mM triethyl
ammonium bicarbonate (pH 7.0).
Syntheses
α-Bromoacetamide-3-cholesterol. 3-α-Aminocholesterol (32)
(20 mg, 0.052 mmol), 1,8-bis-(dimethylamino)naphthalene
(16.72 mg, 0.078 mmol) (Aldrich) and bromoacetylbromide
(12.56 mg, 5.42 µl, 0.062 mmol) (Aldrich) were dissolved in
CH2Cl2 (5 ml). After 30 min at 25C CH2Cl2 (50 ml) was added
and the reaction mixture was extracted with 1 N NaOH (2 × 15 ml)
and water (20 ml). The organic phase was dried over Na2SO4 and
evaporated to dryness. The title compound was isolated by flash
chromatography on SiO2 (Merck) with a linear gradient of MeOH
in CH2Cl2 from 0 to 2%. Yield, orange solid, 17.67 mg (70%). 1H
NMR: (CDCl3) 0.68 (s, 3H, CH3), 0.85 (d, 3H, J = 1.5 Hz, CH3);
0.87 (d, 3H, J = 1.5 Hz, CH3); 0.91 (d, 3H, J = 6.5 Hz, CH3), 1.03
(s, 3H, CH3); 1.07–2.04 (m, 25H); 2.69 (m, 1H); 3.85 (d, 2H,
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Figure 5. 31P NMR spectrum of oligodeoxynucleotide 5′-phosphorothioate C.
J = 0.76 Hz, Br-CH2), 4.11 (m, 1H), 5.45 (d, 1H, J = 5.2 Hz), 6.66
(d, 1H, NH, J = 7.3 Hz). 13C NMR: (CDCl3) 11.9, 18.8, 19.0,
20.9, 22.5, 22.6, 22.9, 23.9, 24.4, 26.1, 28.1, 28.3, 29.8, 31.9,
32.1, 34.5, 35.9, 36.3, 37.1, 37.5, 39.6, 39.8, 42.4, 46.5, 50.9,
56.3, 56.8, 124.4, 138.4, 164.3
2-(5′-Nitropyridyl)-3-cholesterol disulphide. Bis-(5-nitro-2-pyri-
dyl)-disulphide (92.46 mg, 0.3 mmol) (Aldrich) and thio-
cholesterol (80 mg, 0.2 mmol) (Aldrich) were dissolved in
pyridine (4 ml) and stirred at 25C for 2 h. The solvent was
removed in vacuo, the residue dissolved in CH2Cl2 (50 ml) and
extracted with saturated NaHCO3 (20 ml), 1 N NaOH (2 × 15 ml)
and water (20 ml). The organic phase was dried over Na2SO4 and
evaporated to dryness. The title compound was isolated by flash
chromatography on SiO2 (Merck) with a linear gradient of
CH2Cl2 in n-hexane from 0 to 50% (v/v). Yield 88.87 mg (80%).
1H NMR: (CDCl3) 0.66 (s, 3H, CH3), 0.84 (d, 3H, J = 1.6 Hz,
CH3), 0.86 (d, 3H, J = 1.6 Hz, CH3), 0.89 (d, 3H, J = 6.5, CH3),
0.98 (s, 3H, CH3), 1.01–2.02 (m, 26H), 2.35 (m, 2H), 2.83
(m, 1H), 5.34 (d, 1H, J = 4.8 Hz), 7.96 (dd, 1H, J = 0.5 Hz, ArH),
8.40 (dd, 1H, J = 2.6 Hz, ArH), 9.25 (dd, 1H, J = 0.5 Hz, ArH).
13C NMR: (CDCl3) 11.9, 18.8, 19.4, 21.0, 22.6, 22.9, 23.9, 24.3,
28.1, 28.3, 29.0, 31.9, 31.9, 35.9, 36.3, 36.8, 38.9, 39.4, 39.6,
39.8, 42.4, 50.3, 51.0, 56.2, 56.8, 119.2, 122.3, 131.6, 140.8, 142.0,
145.0, 170.1.
Oligodeoxynucleotide 5′-phosphorothioate C. The oligodeoxy-
nucleotide dTTC CTC A was synthesized by standard methods
with the deoxynucleoside phosphoramidites. After the last coupling
of dT, 2′,3′-diacetyluridine-5′-O-(2-cyanoethoxydiisopropyl-
amino)phosphoramidite was added, followed by sulphurization with
Beaucage reagent. For purification the oligonucleotide was base
deprotected and purified by preparative reverse phase HPLC to
result in oligonucleotide A (analytical HPLC, retention time
12.16 min). [M+H]+ calculated 2334.60; found 2332.5.
For the synthesis of the terminal phosphorothioate the oligo-
nucleotide (20 A260 units, 250 nmol) was evaporated to dryness
in a Speed-Vac and the residue dissolved in borax/boric acid
buffer (17.5 µl, 0.06 M, pH 8.6). Sodium periodate was added
(2.5 µl, 200 mM in water) and the reaction was incubated in the
dark at room temperature for 10 min. After this time glycerol
(2 µl) was added, followed again by an incubation for 10 min at
room temperature. For the β-elimination the reaction mixture was
concentrated in a Speed-Vac and then dissolved in NaOH/borax/
boric acid buffer (50 µl, 0.055 M, pH 9.5) and kept at 45C for
90 min. Analytical HPLC indicated 95% conversion to C
(retention time 11.32 min). The crude product was purified by
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Figure 6. Derivatizations of oligodeoxynucleotide 5′-phosphorothioate C.
reverse phase chromatography (Sep-Pak 18 cartridge) as follows.
The Sep-Pak 18 cartridge was prewashed with acetonitrile
(10 ml) followed by triethylammonium bicarbonate (TEAB,
100 mM, pH 7.5, 10 ml). After loading the reaction mixture on the
cartridge, it was first washed with TEAB/4% acetonitrile
(100 mM, pH 7.5, 20 ml) followed by acetonitrile/methanol/
water (35:35:30 v/v, 2 ml). The first 0.4 ml were discarded and the
product collected in the following 1.6 ml. The eluant was
evaporated to dryness and the residue dissolved in water (200 µl).
Dithiothreitol (DTT, 5 µl, 250 mM) was added to this solution to
reduce any disulphide. DTT was removed by extraction with
ethyl acetate (2 × 200 µl). HPLC retention time of C, 11.32 min
(of disulphide, 12.25 min). Yield 83%. 31P NMR (H2O) 45 p.p.m.
(PS) and 0 p.p.m. (PO) (Fig. 5); [M+H]+ calculated 2124.41;
found 2129.7.
For further quantitative analysis the oligonucleotide was
subjected to gel electrophoresis on Hg2+ PAGE ([(N-acryloamino)-
phenyl]mercuric chloride (APM) affinity gel) (20). The oligo-
nucleotide was 3′-end-labelled with [32P]pCp (Amersham;
300 Ci/mmol) using T4 RNA ligase (33) and the sample loaded
on the gel. In this gel the phosphorothioate oligonucleotide barely
moves out of the well. The gel was analysed using a Fuji
BAS-2000 Bio-Imaging PhosphorImager system. The content of
the 5′-phosphorothioate oligonucleotide was 85%. The remaining
15% was 5′-phosphate oligodeoxynucleotide with faster mobility.
Oligodeoxynucleotide 3′-phosphorothioate F. The synthesis was
started with a uridine–CPG column. After the first coupling of the
deoxycytidine phosphoramidite the phosphite triester was reacted
with the Beaucage reagent. The following phosphoramidite
couplings and oxidations to obtain D (retention time 12.09 min)
were carried out as usual. The oligonucleotide was purified by the
normal RNA purification procedure described previously (34).
[M+H]+ for D calculated 2334.60; found 2338.6. Subsequent
oxidation and β-elimination steps to E (retention time 11.60 min)
and F (retention time 11.00 min), respectively, and Sep-Pak
purification were carried out as described for C. Yield of F 85%;
[M+H]+ calculated 2124.41; found 2129.4.
For phosphorothioate quantification on the APM affinity gel,
the oligonucleotide was 5′-labelled with [γ-32P]ATP (35). Content
of the 3′-terminal phosphorothioate oligonucleotide was 83%.
Oligoribonucleotide 3′-phosphorothioate I. The synthesis started
with an adenosine–CPG column. After the first coupling of the
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deoxythymidine phosphoramidite the phosphite triester was
reacted with the Beaucage reagent. The following phosphoramidite
couplings and further purification to obtain I (retention time
11.94 min) were carried out as described above. [M+H]+ for I
calculated 2522.640; found 2525.1.
Subsequent oxidation and β-elimination to H (retention time
11.45 min) and I (retention time 10.69 min), respectively, and
Sep-Pak purification were carried out as described for C. Yield of
I 68%; 31P NMR (H2O) 43 p.p.m. (PS) and 0 p.p.m. (PO);
[M+H]+ calculated 2256.4; found 2261.5.
For phosphorothioate quantification on the APM affinity gel,
the oligonucleotide was 5′-labelled with [γ-32P]ATP as described
for F. Content of the 3′-terminal phosphorothioate oligonucleotide
was 85%.
Derivatisation of oligodeoxynucleotide 5′-phosphorothioate
Oligodeoxynucleotide 5′-bimane derivative J. A solution of 1.5
A260 units (21.4 nmol) of C in HEPES buffer (10 µl, 500 mM,
pH 7.5) was treated with a bromobimane solution (10 µl, 100 mM
in acetonitrile). The reaction was incubated in the dark at room
temperature for 2 h, resulting in a 85% conversion to product. Yield
of L after purification by HPLC 64% (retention time 14.03 min);
λmax 214, 253 and 388 nm; [M+H]+ calculated 2315.62; found
2320.5.
Oligodeoxynucleotide 5′-thiopyridine derivative K. A solution of
1.5 A260 units of C (21.4 nmol) in boric acid/borax buffer (10 µl,
0.06 M, pH 8.6) was treated with dithiodipyridine (10 µl, 100 mM
in acetonitrile). After 2 h at room temperature, the reaction was
86% complete to give K. Yield after HPLC purification 60%;
retention time 14.91 min; [M+H]+ calculated 2234.57; found
2240.4.
Oligodeoxynucleotide 5′-cholesteryl derivative L. A solution of
1.5 A260 units of C (21.4 nmol) in boric acid/borax buffer (3 µl,
0.06 M, pH 8.6) and DMF (7 µl) was treated with a solution of
α-bromoacetamide-3-cholesterol (10 µl, 100 mM in DMF). The
reaction was terminated after 4 h at 37C when the reaction
showed 72% conversion to L. Yield after HPLC purification
31%; retention time 20.99 min; [M+H]+ calculated 2551.12;
found 2557.1.
Oligodeoxynucleotide 5′-disulphide cholesteryl derivative M. A
solution of 1.5 A260 units of C (21.4 nmol) in boric acid/borax
buffer (3 µl, 0.06 M, pH 8.6) and DMF (7 µl) was treated with
2-(5′-nitropyridyl)-3-cholesterol disulphide (10 µl, 25 mM in
DMF). After 24 h at 37C, HPLC analysis indicated ∼52%
conversion to M. Yield after HPLC purification 22% (retention
time 21.31 min); [M+H]+ calculated 2526.13; found 2528.8.
The corresponding oligodeoxynucleotide 3′-derivatives were
synthesized under the same conditions starting with oligo-
deoxynucleotide 3′-phosphorothioate F. For the oligoribonucleotide
3′-phosphorothioate I only the cholesteryl derivatives were
synthesized. In all the syntheses comparable yields were
obtained. All derivatives were characterised by mass spectrometry.
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